Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Europe and North America. It develops and manufactures peptide and small molecule active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. The company offers research products, which include catalog products comprising amino acid derivatives, peptides, and other biochemicals in various packaging sizes for peptide research, small scale peptide synthesis, or other research area; custom synthesis service for peptides and amino acids; sterile peptides under the Clinalfa brand; and glycosylated peptides to improve drug properties. It also provides API products comprising generic APIs used in the fields of cancer, diabetes, obesity, fertility, and others; and new chemical entities. In addition, the company offers customer support services, such as formulation development; sterile tox-vials; compatibility studies; stress tests; post-release stability studies; chemistry, manufacturing, and control documentation for investigational medicinal product dossier and investigational new drug services; and other services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.
bachem holding ag-reg b
(BANB:SIX Swiss Exchange)
Phone: 41 61 935 23 33
Fax: 41 61 935 23 24www.bachem.com
|No competitor information is available for BANB.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact BACHEM HOLDING AG-REG B, please visit www.bachem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.